![Michelle Xia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Xia
Patrimonio netto: 938 M $ in data 31/12/2025
Profilo
Yu Xia ha fondato Akeso, Inc. e Zhongshan Kangfang Biopharma Co. Ltd. Attualmente, il dottor Xia ricopre la posizione di presidente, presidente e amministratore delegato di Akeso, Inc., presidente e direttore generale di Akeso Pharmaceuticals e presidente e amministratore delegato di Zhongshan Kangfang Biopharma Co. Ltd. In passato Yu Xia ha occupato la posizione di vicepresidente senior presso Crown Bioscience, Inc. Yu Xia ha conseguito una laurea presso la Sun Yat-Sen University e un dottorato presso la Newcastle University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/01/2026 | 32.057.147 ( 4,31% ) | 561 M $ | 31/12/2025 | |
AKESO, INC. 2,82% | 04/09/2025 | 26.000.000 ( 2,82% ) | 377 M $ | 31/12/2025 |
Ultime notizie su Michelle Xia
Posizioni attive di Michelle Xia
| Società | Posizione | Inizio |
|---|---|---|
| AKESO, INC. | Amministratore Delegato | 19/03/2012 |
| SUMMIT THERAPEUTICS INC. | Direttore/Membro del Consiglio | 16/01/2023 |
Zhongshan Kangfang Biopharma Co. Ltd.
 Zhongshan Kangfang Biopharma Co. Ltd. Discovers and develops biologics with international intellectual rights for the treatment of a broad spectrum of diseases | Amministratore Delegato | 01/03/2012 |
AD Pharmaceuticals Co., Ltd
 AD Pharmaceuticals Co., Ltd Manufactures and provides pharmaceutical services | Amministratore Delegato | - |
Precedenti posizioni note di Michelle Xia
| Società | Posizione | Fine |
|---|---|---|
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Corporate Officer/Principal | 01/03/2012 |
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01/01/2008 |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Corporate Officer/Principal | - |
Akeso Pharmaceuticals CJSC
 Akeso Pharmaceuticals CJSC Engage in selling of medical supplies | Presidente | - |
Formazione di Michelle Xia
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Health Technology |
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization for drug discovery | Commercial Services |
Newcastle University
 Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Sun Yat-Sen University
 Sun Yat-Sen University Functions as a College/University | |
Akeso Pharmaceuticals CJSC
Akeso Pharmaceuticals CJSC Engage in selling of medical supplies | |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. Develops biopharmaceutical products | |
Zhongshan Kangfang Biopharma Co. Ltd.
Zhongshan Kangfang Biopharma Co. Ltd. Discovers and develops biologics with international intellectual rights for the treatment of a broad spectrum of diseases | |
Akeso, Inc.
 Akeso, Inc. Develops, manufactures and commercializes therapeutic antibodies to patients | |
AD Pharmaceuticals Co., Ltd
AD Pharmaceuticals Co., Ltd Manufactures and provides pharmaceutical services |
